PLENARY SESSION: TISSUE INJURY, TISSUE REPAIR, AND PREVENTION OF CARCINOGENESIS
8:00 a.m. to 10:00 a.m.
Chairperson: Michael B. Sporn, Dartmouth Medical School, Hanover, NH
Integrating Inflammation
Carl F. Nathan, Cornell Medical College, New York, NY
Oxidative Damage to DNA and Proteins
Lawrence J. Marnett, Vanderbilt University, Nashville, TN
Inflammatory Angiogenesis: A Target for Chemoprevention
Adriana Albini, IRCCS Multimedica, Milan, Italy
New Agents for Chemoprevention
Michael B. Sporn
CONCURRENT SESSIONS
10:15 a.m. to 12:15 p.m.
Colorectal Cancer Prevention
Chairperson: Monica M. Bertagnolli, Brigham and Women's Hospital, Boston, MA
Overview
Monica M. Bertagnolli
New Genetic Targets in Colon Cancer Prevention
Sanford D. Markowitz, Case Western Reserve University, Cleveland, OH
The Role of JC Virus in Colorectal Carcinogenesis
C. Richard Boland, Baylor University Medical Center, Dallas, TX
Use of Animal Models in Colorectal Cancer Prevention
Steven Gallinger, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
Proffered Paper Presentation
Head and Neck Cancer: Risk Assessment and Prevention
Chairperson: Jennifer Rubin Grandis, University of Pittsburgh, Pittsburgh, PA
Overview
Jennifer Rubin Grandis
Identification of High-risk Oral Premalignant Lesions
Miriam P. Rosin, British Columbia Cancer Research Center, Vancouver, BC, Canada
Application of Molecular Markers in Head and Neck Cancer
David Sidransky, Johns Hopkins University School of Medicine, Baltimore, MD
Overview of Chemoprevention Strategies for Head and Neck Cancer
Vassiliki A. Papadimitrakopoulou, UT M. D. Anderson Cancer Center, Houston, TX
Proffered Paper Presentation
Immunoprevention of Cancer: Future, not Fantasy
Chairperson: Louis M. Weiner, Fox Chase Cancer Center, Philadelphia, PA
Overview
Louis M. Weiner
Cancer Immunoediting: A Role for Immunity in Promoting Tumor Elimination, Persistence, and Progression
Robert D. Schreiber, Washington University, Saint Louis, MO
Vaccines Based on Self (Tumor)-Antigens: Accomplishments and Challenges
Olivera J. Finn, University of Pittsburgh School of Medicine, Pittsburgh, PA
Challenges for Cancer Vaccine Development in the Academic and Commercial Sectors
Martin A. Cheever, Fred Hutchinson Cancer Research Center, Seattle, WA
Proffered Paper Presentation
Pancreatic Cancer: Strategies for Early Diagnosis and Prevention
Co-Chairpersons: James L. Abbruzzese, UT M. D. Anderson Cancer Center, Houston, TX, and David A. Tuveson, Cancer Research UK, Cambridge Research Institute, Cambridge, England
Overview
James L. Abbruzzese
Histologic Precursors of Pancreatic Cancer
Anirban Maitra, Johns Hopkins University, Baltimore, MD
Pancreatic Cancer Medicine in Mice
David A. Tuveson
Molecular Cancer Prevention: Phase IIa Trial of Erlotinib for IPMNs and the Prevention of Pancreatic Cancer
Steven M. Lipkin, University of California, Irvine, CA
Proffered Paper Presentation
Youth Risk Behaviors for Cancer Prevention: Analysis and Intervention
Chairperson: Ellen R. Gritz, UT M. D. Anderson Cancer Center, Houston, TX
Overview
Ellen R. Gritz
Innovative Approaches to Prevention and Cessation of Youth Tobacco Use
Alexander V. Prokhorov, UT M. D. Anderson Cancer Center, Houston, TX
The Protective Role of Physical Activity on Adolescent Smoking Progression
Janet Audrain-McGovern, University of Pennsylvania, Philadelphia, PA
The Overweight Epidemic Among Children and Youth in the United States: Causes and Some Opportunities for Prevention
Steven L. Gortmaker, Harvard School of Public Health, Boston, MA
Eating Behavior Change Interventions and Prevention of Obesity in Children
Leslie A. Lytle, University of Minnesota, Minneapolis, MN
REPORT: C-CHANGE CANCER PREVENTION RESEARCH SUMMIT
12:30 p.m. to 1:45 p.m.
Chairperson: Ronald B. Herberman, University of Pittsburgh, Pittsburgh, PA
Panelists
- Scott M. Lippman, UT M. D. Anderson Cancer Center, Houston, TX
- David S. Alberts, Arizona Cancer Center, Tucson, AZ
- Bruce C. Pyenson, Milliman, Inc., New York, NY
- Catherine P. Bennett, Venable LLP, Washington, DC
PLENARY SESSION: NUTRITION, ACTIVITY, OBESITY, AND CANCER
2:00 p.m. to 4:00 p.m.
Chairperson: Karen Glanz, Emory University, Atlanta, GA
Physical Activity and Cancer: Progress and "Opportunities"
Leslie Bernstein, USC/Norris Comprehensive Cancer Center, Los Angeles, CA
Diet and Cancer: The Fourth Paradigm
Walter C. Willett, Harvard School of Public Health, Boston, MA
Community Approaches to Obesity Treatment and Prevention
Robert W. Jeffery, University of Minnesota, Minneapolis, MN
POSTER SESSION A
4:00 p.m. to 6:00 p.m.
BEHAVIORAL SCIENCE NETWORKING EVENT
6:00 p.m. to 7:30 p.m.
Co-Chairpersons: Sharon L. Manne, Fox Chase Cancer Center, Philadelphia, PA, and Michael Stefanek, American Cancer Society, Atlanta, GA
MEG/AACR SPECIAL SESSION
6:00 p.m. to 7:30 p.m.
Organized by the Molecular Epidemiology Working Group (MEG/AACR)
The Genes and Environment Initiative: Opportunities for Genomics and Epigenetics in Molecular Epidemiology
David A. Schwarz, National Institute of Environmental Health Sciences, Research Triangle Park, NC